SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cadus Corp – ‘S-8 POS’ on 4/5/16

On:  Tuesday, 4/5/16, at 9:19am ET   ·   Effective:  4/5/16   ·   Accession #:  1144204-16-92715   ·   File #:  333-58151

Previous ‘S-8 POS’:  ‘S-8 POS’ on 4/5/16   ·   Latest ‘S-8 POS’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/05/16  Cadus Corp                        S-8 POS     4/05/16    1:18K                                    Vintage/FA

Post-Effective Amendment to an S-8   —   Form S-8
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8 POS     Post-Effective Amendment No. 1                      HTML     12K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

As filed with the Securities and Exchange Commission on April 5, 2016

Registration Statement No. 333-58151

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
REGISTRATION STATEMENT NO. 333-58151

 

UNDER THE SECURITIES ACT OF 1933

 

 

 

Cadus Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   13-3660391

(State or Other Jurisdiction

of Incorporation)

 

(IRS Employer

Identification No.)

     

767 Fifth Avenue, Suite 4700

New York, New York

  10153
(Address of Principal Executive Offices)   (Zip Code)

 

 

 

Cadus Pharmaceutical Corporation 1996 Incentive Plan

 

 

 

Hunter C. Gary

President and Chief Executive Officer

Cadus Corporation

767 Fifth Avenue, Suite 4700

New York, New York 10153

(name and address of agent for service)

 

(212) 702-4300

(Telephone number, including area code, of agent for service)

 

 

 

Copy to:

 

Salomon R. Sassoon, Esq.

Matthew Der Manuelian, Esq.

Morrison Cohen LLP

909 Third Avenue

New York, New York 10022

(212) 735-8654

 

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer ¨   Accelerated filer ¨
Non-accelerated filer ¨ (Do not check if a smaller reporting company)   Smaller reporting company x

 

 

 

 

EXPLANATORY STATEMENT

 

Cadus Corporation, formerly known as Cadus Pharmaceutical Corporation (the “Registrant”), previously registered shares of the Registrant’s common stock, par value $0.01 per share (“Common Stock”), under registration statement on Form S-8 (the “Registration Statement”) concerning shares of Common Stock issuable or issued under the Registrant’s 1996 Incentive Plan (the “Plan”). The Registrant is no longer issuing securities under the Plan. This Post-Effective Amendment No. 1 is being filed to deregister the remaining unissued shares of Common Stock that were registered for issuance pursuant to the below-referenced Registration Statement in connection with the Plan:

 

·Registration Statement on Form S-8 (No. 333-58151) filed by the Registrant with the SEC on June 30, 1998.

 

Accordingly, the Registrant hereby withdraws from registration under the Registration Statement on Form S-8 all of the shares of its Common Stock that have not been and will not be issued under the Plan.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, and Rule 478 thereunder, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, the 5th day of April, 2016.

 

   CADUS CORPORATION  
         
         
  By: /s/ Hunter C. Gary  
    Name: Hunter C. Gary  
    Title: President and Chief Executive Officer  

 

Note: No other person is required to sign this Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-58151 in reliance upon Rule 478 under the Securities Act of 1933.

 

 

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-8 POS’ Filing    Date    Other Filings
Filed on / Effective on:4/5/168-K,  S-8 POS
6/30/9810-Q,  S-8
 List all Filings 
Top
Filing Submission 0001144204-16-092715   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 12:42:00.1pm ET